XenaCare Holdings to advertise OTC pain reliever in NASCAR’s annual publication

XenaCare Holdings, Inc. (OTCBB: XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it has signed an agreement to market its over-the-counter (OTC) pain reliever, Cobroxin, in Racing One, the official annual publication of NASCAR, for the 2010 racing season. Cobroxin is currently available online at Cobroxin.com and will be available soon at various retail outlets.

The 2010 Racing One Annual, which will be available starting at the 52nd anniversary of the NASCAR Sprint Cup DAYTONA 500 in February 2010, will be sold through the end of the season. In addition to reaching approximately 8.5 million NASCAR fans attending the 78 NASCAR events being held at the 26 NASCAR sanctioned racetracks, the Publication will also be sold throughout North America in major newsstands, bookstores, grocery stores, retail outlets, train stations, and airports.

“We are excited to be advertising Cobroxin in the 2010 Racing One Annual, as it offers us the opportunity to build awareness around Cobroxin by introducing it through NASCAR, the fastest growing spectator sport in the United States,” commented Frank Rizzo, President of XenaCare Holdings. “We look forward to beginning this campaign and continuing to expand our marketing efforts as we introduce Cobroxin through retailers across the United States,” he added.

In addition to the Company’s agreement to market Cobroxin in NASCAR’s Racing One, XenaCare Holdings will also be advertising Cobroxin in the 2009 NFL Alumni Guide and Yearbook. Additionally, the Company announced plans to begin its initial print marketing campaign this fall, which includes advertising in Prevention, Health, Star, Woman's World, Soap Opera, and Self Magazines.

XenaCare Holdings, which holds the exclusive license from Nutra Pharma Corporation (OTCBB: NPHC) to market and distribute Cobroxin in the United States, announced on Monday that it had begun accepting orders for Cobroxin online at Cobroxin.com. The Company intends to announce both online and brick-and-mortar retailers in the coming weeks as they begin offering Cobroxin for sale to consumers.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Myocarditis risks linked to COVID-19 vaccination explained